Mirae Asset Global ETFs Holdings
LENZ

Mirae Asset Global ETFs Holdings’s LENZ Therapeutics LENZ Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$85.7K Buy
9,371
+1,836
+24% +$25.8K ﹤0.01% 2730
2025
Q4 		$121K Buy
7,535
+55
+0.7% +$1.6K ﹤0.01% 2582
2025
Q3 		$348K Sell
7,480
-2,267
-23% -$83.4K ﹤0.01% 2041
2025
Q2 		$286K Buy
9,747
+2,222
+30% +$60.4K ﹤0.01% 2092
2025
Q1 		$193K Sell
7,525
-389
-5% -$9.58K ﹤0.01% 2339
2024
Q4 		$229K Buy
7,914
+1,005
+15% +$30.6K ﹤0.01% 2324
2024
Q3 		$164K Buy
6,909
+5,282
+325% +$117K ﹤0.01% 2470
2024
Q2 		$28.1K Buy
+1,627
New +$28.4K ﹤0.01% 2881

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's LENZ Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its LENZ Therapeutics (LENZ) stake by 24% in Q1 2026, buying an estimated $25.8K and bringing the position to 9,371 shares worth $85.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2730.

Mirae Asset Global ETFs Holdings first reported a position in LENZ in Q2 2024 and has held it in 8 quarters since. The position peaked at $348K in Q3 2025. 145 funds tracked by Wall St. Rank hold LENZ as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 9,371 shares of LENZ Therapeutics worth $85.7K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 1,836 LENZ Therapeutics shares in Q1 2026, an estimated $25.8K.
  • LENZ Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2730 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in LENZ Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • Mirae Asset Global ETFs Holdings's LENZ Therapeutics position peaked at $348K in Q3 2025.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.